A FITC-conjugated form of semaglutide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Semaglutide (FITC labeled)

Item No. 44292

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • FITC-Semaglutide
  • FITC-SET
Purity
≥95%
Emission
535 nm
Excitation
485 nm
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥10 mg/mlPBS: Sparingly Soluble: 1-10 mg/ml
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $229

    Add

    5 mg

    $573

    Add

    10 mg

    $916

    Add

    25 mg

    $1,431

    Add
    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Semaglutide (FITC labeled) is a FITC-conjugated form of the glucagon-like peptide 1 (GLP-1) agonist semaglutide (Item Nos. 40231 | 29969 | 40170). Semaglutide (FITC labeled) has been used in the study of milk exosome-based hybrid vesicle movement and penetration capacity in porcine intestinal mucus ex vivo.1 It has also been used in the study of hybrid vesicle permeability in Caco-2/E12 co-cultured cells as a model of mucosal tissue and in the study of intestinal epithelial uptake in rats. FITC displays excitation/emission maxima of 485/535 nm, respectively.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Xiao, P., Yuan, H., Liu, H., et al. Modulating the elasticity of milk exosome-based hybrid vesicles to optimize transepithelial transport and enhance oral peptide delivery. J. Control Release 380, 36-51 (2025).